Difference between revisions of "Part:BBa K4165045"
Line 6: | Line 6: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | Switch 25 | + | Switch 25 is used to mediate the activity of HTRA1. It is composed of 3 parts connected by different linkers; an HtrA1 PDZ peptide, a clamp of two targeting peptides for tau or amyloid beta, and a catalytic domain inhibitor. Activating HTRA1 requires a conformational change in the linker, eliminating the attached inhibitor from the active site. The conformational rearrangement can be mediated through the binding of affinity clamp to tau or beta-amyloid. This binding will result in a tension that detaches the inhibitor from the active site. |
Line 15: | Line 15: | ||
===Dry lab=== | ===Dry lab=== | ||
<p style=" font-weight: bold; font-size:14px;"> Modeling </p> | <p style=" font-weight: bold; font-size:14px;"> Modeling </p> | ||
− | + | The switch was modeled by (Alphafold - Rosettafold - tRrosetta) and the top model was obtained from tRrosseta with a score of 4 out of 6 according to our quality assessment code. | |
<html> | <html> | ||
− | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/switch25.png" style="margin-left: | + | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/switch25.png" style="margin-left:220px;" alt="" width="500" /></p> |
</html> | </html> | ||
Revision as of 17:47, 11 October 2022
HtrA1 Switch 25
This composite part consists of T7 promoter (BBa_K3633015), lac operator (BBa_K4165062), pGS-21a RBS (BBa_K4165016), 6x His-tag (BBa_K4165020), H1A (BBa_K4165000), GGGGSG Linker (BBa_K4165017), Seed peptide (BBa_K4165012), GGSGGGGG Linker (BBa_K4165019), Seed peptide (BBa_K4165012), GGGGSG Linker (BBa_K4165017), WAP inhibitor (BBa_K4165008), and T7 terminator (BBa_K731721).
Usage and Biology
Switch 25 is used to mediate the activity of HTRA1. It is composed of 3 parts connected by different linkers; an HtrA1 PDZ peptide, a clamp of two targeting peptides for tau or amyloid beta, and a catalytic domain inhibitor. Activating HTRA1 requires a conformational change in the linker, eliminating the attached inhibitor from the active site. The conformational rearrangement can be mediated through the binding of affinity clamp to tau or beta-amyloid. This binding will result in a tension that detaches the inhibitor from the active site.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 379
Illegal AgeI site found at 115 - 1000COMPATIBLE WITH RFC[1000]
Dry lab
Modeling
The switch was modeled by (Alphafold - Rosettafold - tRrosetta) and the top model was obtained from tRrosseta with a score of 4 out of 6 according to our quality assessment code.
Figure 1. The 3D structure of switch 25 modeled by TRrosetta.